Empowering Pharmacoinformatics by Linked Life Science Data

Overview

Journal J Comput Aided Mol Des

Publisher Springer

Specialties Biomedical Engineering
Molecular Biology

Date 2016 Nov 11

PMID 27830428

Authors

Daria Goldmann

Barbara Zdrazil

Daniela Digles

Gerhard F Ecker

Affiliations

Soon will be listed here.

Abstract

With the public availability of large data sources such as ChEMBLdb and the Open PHACTS Discovery Platform, retrieval of data sets for certain protein targets of interest with consistent assay conditions is no longer a time consuming process. Especially the use of workflow engines such as KNIME or Pipeline Pilot allows complex queries and enables to simultaneously search for several targets. Data can then directly be used as input to various ligand- and structure-based studies. In this contribution, using in-house projects on P-gp inhibition, transporter selectivity, and TRPV1 modulation we outline how the incorporation of linked life science data in the daily execution of projects allowed to expand our approaches from conventional Hansch analysis to complex, integrated multilayer models.

References

Azzaoui K, Jacoby E, Senger S, Rodriguez E, Loza M, Zdrazil B . Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today. 2013; 18(17-18):843-52. DOI: 10.1016/j.drudis.2013.05.008. View

Zdrazil B, Hellsberg E, Viereck M, Ecker G . From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter. Medchemcomm. 2016; 7(9):1819-1831. PMC: 5100691. DOI: 10.1039/c6md00207b. View

Steenland H, Ko S, Wu L, Zhuo M . Hot receptors in the brain. Mol Pain. 2006; 2:34. PMC: 1647269. DOI: 10.1186/1744-8069-2-34. View

Kym P, Kort M, Hutchins C . Analgesic potential of TRPV1 antagonists. Biochem Pharmacol. 2009; 78(3):211-6. DOI: 10.1016/j.bcp.2009.02.014. View

Aller S, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R . Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 2009; 323(5922):1718-22. PMC: 2720052. DOI: 10.1126/science.1168750. View

Liao M, Cao E, Julius D, Cheng Y . Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature. 2013; 504(7478):107-12. PMC: 4078027. DOI: 10.1038/nature12822. View

Williams A, Harland L, Groth P, Pettifer S, Chichester C, Willighagen E . Open PHACTS: semantic interoperability for drug discovery. Drug Discov Today. 2012; 17(21-22):1188-98. DOI: 10.1016/j.drudis.2012.05.016. View

Westaway S . The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain. J Med Chem. 2007; 50(11):2589-96. DOI: 10.1021/jm060637e. View

Lee J, Lee Y, Ryu H, Kang D, Lee J, Lazar J . Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies. J Comput Aided Mol Des. 2011; 25(4):317-27. PMC: 3420359. DOI: 10.1007/s10822-011-9421-5. View

10.

Elefsinioti A, Bellaire T, Wang A, Quast K, Seidel H, Braxenthaler M . Key factors for successful data integration in biomarker research. Nat Rev Drug Discov. 2016; 15(6):369-70. DOI: 10.1038/nrd.2016.74. View

11.

Karapetyan K, Batchelor C, Sharpe D, Tkachenko V, Williams A . The Chemical Validation and Standardization Platform (CVSP): large-scale automated validation of chemical structure datasets. J Cheminform. 2015; 7:30. PMC: 4494041. DOI: 10.1186/s13321-015-0072-8. View

12.

Goldmann D, Montanari F, Richter L, Zdrazil B, Ecker G . Exploiting open data: a new era in pharmacoinformatics. Future Med Chem. 2014; 6(5):503-14. DOI: 10.4155/fmc.14.13. View

13.

Zdrazil B, Chichester C, Zander Balderud L, Engkvist O, Gaulton A, Overington J . Transporter assays and assay ontologies: useful tools for drug discovery. Drug Discov Today Technol. 2014; 12:e47-54. DOI: 10.1016/j.ddtec.2014.03.005. View

14.

Ecker G, Huber M, Schmid D, Chiba P . The importance of a nitrogen atom in modulators of multidrug resistance. Mol Pharmacol. 1999; 56(4):791-6. View

15.

Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W . The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007; 25(11):1251-5. PMC: 2814061. DOI: 10.1038/nbt1346. View

16.

Wolber G, Langer T . LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2005; 45(1):160-9. DOI: 10.1021/ci049885e. View

17.

Chen L, Li Y, Zhao Q, Peng H, Hou T . ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol Pharm. 2011; 8(3):889-900. DOI: 10.1021/mp100465q. View

18.

Yang F, Xiao X, Cheng W, Yang W, Yu P, Song Z . Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel. Nat Chem Biol. 2015; 11(7):518-524. PMC: 4472570. DOI: 10.1038/nchembio.1835. View

19.

Langer T, Eder M, Hoffmann R, Chiba P, Ecker G . Lead identification for modulators of multidrug resistance based on in silico screening with a pharmacophoric feature model. Arch Pharm (Weinheim). 2004; 337(6):317-27. DOI: 10.1002/ardp.200300817. View

20.

Lee J, Shinn P, Jaken S, Oliver S, Willard F, Heidler S . Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays. PLoS One. 2015; 10(7):e0130796. PMC: 4503722. DOI: 10.1371/journal.pone.0130796. View